过去一年中添加的文章，按日期排序
Thymic epithelial tumor medical treatment: A narrative review
Q Huang, L Zhu, Y Liu, Y Zhang - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
35 天前 - … thymomas, is limited owing to immune-related adverse effects. Here, we have …
immune checkpoint inhibitors in thymic epithelial tumors, to provide a holistic treatment …
immune checkpoint inhibitors in thymic epithelial tumors, to provide a holistic treatment …
Patient-Reported Outcomes with First-Line Immunotherapy-Based Combination Treatment for Advanced Lung Cancer: A Prospective, Multicentre, Observational Study
R Jia, J Zou, H Hu, X Wang, Y Zheng, F Yang, Y Pang… - papers.ssrn.com
35 天前 - … monitoring of responses to immune checkpoint inhibitor (ICI) therapy are scarce. …
an immune-related adverse event symptom item scale, we collected the ePRO data of patients …
an immune-related adverse event symptom item scale, we collected the ePRO data of patients …
[HTML][HTML] Cardiac Troponin I and T in ICI Myocarditis Screening, Diagnosis, and Prognosis
A Barac, RC Wadlow, JF Deeken, C deFilippi - Cardio Oncology, 2024 - jacc.org
36 天前 - … Immune checkpoint inhibitors (ICIs) have become a key pillar in the oncology treatment
… is counterbalanced by the risk of immune-related adverse events. These span from mild …
… is counterbalanced by the risk of immune-related adverse events. These span from mild …
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic …
E Hysa, A Casabella, E Gotelli, R Campitiello… - Autoimmunity …, 2024 - Elsevier
36 天前 - … Inhibition of these checkpoints can lead to immune-related adverse reactions (irAEs), …
different subgroups, including patients treated with PD1-PDL1 inhibitors, CTLA4 blockers …
different subgroups, including patients treated with PD1-PDL1 inhibitors, CTLA4 blockers …
Immunotherapy and its effect on the inner ear, an evolving story
L Decraene, H Van Hoecke, C Braet… - BELGIAN JOURNAL …, 2024 - biblio.ugent.be
36 天前 - … Abstract Immune checkpoint inhibitors (ICI) are an … However, immune-related adverse
events (irAEs) are still … in thirteen patients with melanoma or NSCLC treated with an ICI. A …
events (irAEs) are still … in thirteen patients with melanoma or NSCLC treated with an ICI. A …
[PDF][PDF] Neurological immune-related toxicity to ipilimumab/nivolumab therapy in malignant melanoma: A challenging
DB da Mata, PR Rodrigues, V Oliveira, FV Santos… - survival (OS) - ijcrioncology.com
37 天前 - … However, the rising use of immune checkpoint inhibitors (ICIs) introduces …
immune-related adverse events (irAEs). Though uncommon, the diagnosis of these effects poses …
immune-related adverse events (irAEs). Though uncommon, the diagnosis of these effects poses …
Anti-asparaginyl-tRNA synthetase antibody-positive pneumonitis in a patient with immune checkpoint inhibitor treatment: A case report and literature review
N Oda, O Koguchi, H Kontani, J Hayashi… - Modern …, 2024 - academic.oup.com
37 天前 - … In recent years, the number of cancer patients eligible for immune checkpoint
inhibitors (ICIs) has been increasing, and the clinical spectrum of immune-related adverse events (…
inhibitors (ICIs) has been increasing, and the clinical spectrum of immune-related adverse events (…
40 Preclinical evaluation of a novel dendritic cell vaccine for kidney cancer
37 天前 - … to assess immune-related adverse events (iRAE… immune-check point inhibitors
(ICI)/anti-angiogenic therapy remains modest and is limited to a small minority of ccRCC patients…
(ICI)/anti-angiogenic therapy remains modest and is limited to a small minority of ccRCC patients…
59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
37 天前 - … first-line treatment in patients with … immune-related adverse events (irAEs). Herein,
we aimed to identify risk factors of immune related adverse events (irAEs) in patients treated …
we aimed to identify risk factors of immune related adverse events (irAEs) in patients treated …
Machine learning modeling of patient health signals informs long-term survival on immune checkpoint inhibitor therapy
GJ Sun, G Arango-Argoty, GJ Doherty, DE Bikiel… - iScience, 2024 - cell.com
39 天前 - … of immune-related adverse events. Only our signature was predictive and
identified longer survivors in patients treated with durvalumab but not in patients treated with …
identified longer survivors in patients treated with durvalumab but not in patients treated with …